New platform coming soon — AI-Based Analysis with Human-Generated Insights

Market News & Insights

US Analyst Updates — October 20th, 2026

US Analyst Updates — October 20th, 2026
The overall U.S. analyst outlook remains cautious, with 107 price target reductions significantly outnumbering 51 increases, suggesting growing concerns over stock valuations, earnings expectations, and broader economic uncertainty. While selective opportunities remain in technology, healthcare, and other growth-oriented sectors, analysts appear increasingly focused on downside risks, profitability, and earnings sustainability. The imbalance in target revisions points to a more defensive market environment, with heightened volatility and the potential for further valuation adjustments, although selective upgrades indicate that confidence remains in companies with strong fundamentals and resilient growth prospects.

Updates (354)

Abivax (ABVX) — Guggenheim reiterated its rating of Buy with a $175.00 price target.

Absci (ABSI) — HC Wainwright reiterated its rating of Buy.

Accel Entertainment (ACEL) — Truist Financial lowered its price target to $13.00 from $14.00 and maintained its Hold rating.

Acuity (AYI) — Morgan Stanley lowered its price target to $380.00 from $410.00 and maintained its Overweight rating.

ADARx Pharmaceuticals (ADRX) — JPMorgan initiated at Overweight with a $38.00 price target.

ADARx Pharmaceuticals (ADRX) — Morgan Stanley initiated at Overweight with a $32.00 price target.

ADARx Pharmaceuticals (ADRX) — TD Cowen initiated at Buy.

ADARx Pharmaceuticals (ADRX) — UBS initiated at Buy with a $35.00 price target.

Advanced Micro Devices (AMD) — Wedbush reiterated its rating of Outperform with a $600.00 price target.

Agree Realty (ADC) — Barclays lowered its price target to $76.00 from $85.00 and maintained its Equal Weight rating.

Akamai Technologies (AKAM) — Raymond James upgraded from Outperform to Strong Buy with a $170.00 price target.

Albemarle (ALB) — Truist Financial lowered its price target to $185.00 from $225.00 and maintained its Buy rating.

Alcoa (AA) — B. Riley Financial lowered its price target to $63.00 from $80.00 and maintained its Buy rating.

Alcoa (AA) — DA Davidson set a price target of $62.00.

Alcoa (AA) — Freedom Broker lowered its price target to $62.00 from $76.00 and maintained its Buy rating.

Allegro MicroSystems (ALGM) — Wells Fargo & Company lowered its price target to $45.00 from $56.00 and maintained its Overweight rating.

Almonty Industries (ALM) — Stifel lowered its price target to $21.00 from $25.00 and maintained its Buy rating.

Alpha Tau Medical (DRTS) — HC Wainwright reiterated its rating of Buy with a $16.00 price target.

Alphabet (GOOG) — BMO Capital Markets reiterated its rating of Outperform with a $480.00 price target.

Alphabet (GOOGL) — BMO Capital Markets reiterated its rating of Outperform with a $480.00 price target.

Amazon.com (AMZN) — BMO Capital Markets reiterated its rating of Buy.

Ameren (AEE) — BMO Capital Markets lowered its price target to $113.00 from $119.00 and maintained its Outperform rating.

American Airlines Group (AAL) — Sanford C. Bernstein set a price target of $19.00.

American Electric Power (AEP) — BTIG Research upgraded from Neutral to Buy with a $147.00 price target.

American Tower (AMT) — Sanford C. Bernstein lowered its price target to $212.00 from $214.00 and maintained its Outperform rating.

Americold Realty Trust (COLD) — UBS Group lowered its price target to $14.00 from $16.00 and maintained its Neutral rating.

Amkor Technology (AMKR) — B. Riley Financial lowered its price target to $46.00 from $65.00 and maintained its Neutral rating.

Amplitude (AMPL) — BTIG Research raised its price target to $17.00 from $13.00 and maintained its Buy rating.

Amtech Systems (ASYS) — Lake Street initiated at Buy with a $22.00 price target.

APA (APA) — Susquehanna raised its price target to $58.00 from $47.00 and maintained its Positive rating.

Apple (AAPL) — Loop Capital downgraded from Buy to Hold with a $330.00 price target.

Apple (AAPL) — Moffett Nathanson set a price target of $283.00 with a Neutral rating.

Applied Materials (AMAT) — Cantor Fitzgerald reiterated its rating of Outperform.

argenex (ARGX) — Royal Bank Of Canada lowered its price target to $1,025.00 from $1,100.00 and maintained its Outperform rating.

Arhaus (ARHS) — Piper Sandler upgraded from Neutral to Overweight with a $13.00 price target.

Arhaus (ARHS) — Telsey Advisory Group reiterated its rating of Overweight.

Arlo Technologies (ARLO) — Piper Sandler lowered its price target to $16.00 from $18.00 and maintained its Overweight rating.

ArriVent BioPharma (AVBP) — B. Riley Financial lowered its price target to $29.00 from $45.00 and maintained its Buy rating.

Artivion (AORT) — Jefferies initiated at Buy with a $31.00 price target.

Atlassian (TEAM) — BTIG Research raised its price target to $260.00 from $230.00 and maintained its Buy rating.

Atlassian (TEAM) — Citigroup reiterated its rating of Hold.

Axon Enterprise (AXON) — Piper Sandler lowered its price target to $561.00 from $732.00 and maintained its Overweight rating.

Banco Santander (SAN) — Jefferies reiterated its rating of Buy ? Hold.

Bancorp (TBBK) — DA Davidson set a price target of $64.00.

Bancorp (TBBK) — Royal Bank Of Canada reiterated its rating of Outperform with a $60.00 price target.

Baxter (BAX) — Wolfe Research initiated at Peer Perform.

Becton Dickinson (BDX) — Wolfe Research initiated at Outperform.

Best Buy (BBY) — Evercore set a price target of $95.00.

Bicara Therapeutics (BCAX) — Morgan Stanley reiterated its rating.

Biogen (BIIB) — Wells Fargo & Company raised its price target to $310.00 from $250.00 and maintained its Overweight rating.

BioMarin Pharmaceutical (BMRN) — Cantor Fitzgerald reiterated its rating of Overweight with a $86.00 price target.

BioMarin Pharmaceutical (BMRN) — JPMorgan raised its price target to $87.00 from $86.00 and maintained its Overweight rating.

BlackRock (BLK) — TD Cowen upgraded from Hold to Buy with a $1,405.00 price target.

BOK Financial (BOKF) — DA Davidson set a price target of $147.00.

BOK Financial (BOKF) — Jefferies reiterated its rating of Buy with a $150.00 price target.

Booking (BKNG) — Melius Research set a price target of $225.00.

Boston Scientific (BSX) — TD Cowen reiterated its rating of Neutral.

Boyd Gaming (BYD) — JPMorgan lowered its price target to $85.00 from $93.00 and maintained its Neutral rating.

Boyd Gaming (BYD) — Truist Financial lowered its price target to $100.00 from $110.00 and maintained its Buy rating.

BP (BP) — DA Davidson set a price target of $49.00.

BP (BP) — TD Cowen raised its price target to $49.00 from $47.00 and maintained its Hold rating.

Braveheart Bio (BRVE) — Cantor Fitzgerald reiterated its rating of Overweight with a $40.00 price target.

Braze (BRZE) — Cantor Fitzgerald downgraded its rating from Overweight to Neutral.

Braze (BRZE) — Loop Capital downgraded its rating from Buy to Hold and set a $47.50 price target.

Braze (BRZE) — Needham & Company LLC downgraded its rating from Buy to Hold.

Braze (BRZE) — Oppenheimer downgraded its rating from Outperform to Market Perform.

Braze (BRZE) — Piper Sandler downgraded its rating from Overweight to Neutral and adjusted its price target to $47.50 from $30.00.

Braze (BRZE) — Stifel reiterated its rating of Buy ? Hold with a $47.50 price target.

Braze (BRZE) — Wells Fargo & Company downgraded its rating from Overweight to Positive and set a $47.50 price target.

Braze (BRZE) — William Blair downgraded its rating from Overweight to Neutral.

BridgeBio Oncology Therapeutics (BBOT) — Oppenheimer lowered its price target to $16.00 and maintained its Outperform rating.

Brightstar Lottery (BRSL) — Truist Financial lowered its price target to $11.00 from $13.00 and maintained its Hold rating.

Camtek (CAMT) — B. Riley Financial lowered its price target to $166.00 from $200.00 and maintained its Buy rating.

Cardinal Health (CAH) — Mizuho raised its price target to $280.00 from $250.00 and maintained its Outperform rating.

Carter’s (CRI) — Needham & Company LLC reiterated its rating.

Cencora (COR) — Argus raised its price target to $380.00 from $340.00 and maintained its Buy rating.

Centrus Energy (LEU) — Needham & Company LLC lowered its price target to $206.00 from $262.00 and maintained its Buy rating.

Centrus Energy (LEU) — Roth Capital set a price target of $115.00.

Chemours (CC) — Truist Financial lowered its price target to $20.00 from $24.00 and maintained its Buy rating.

Chevron (CVX) — The Goldman Sachs Group reiterated its rating of Buy with a $241.00 price target.

Chord Energy (CHRD) — UBS Group raised its price target to $197.00 from $193.00 and maintained its Buy rating.

Churchill Downs (CHDN) — JPMorgan lowered its price target to $118.00 from $123.00 and maintained its Overweight rating.

Churchill Downs (CHDN) — Truist Financial lowered its price target to $140.00 from $145.00 and maintained its Buy rating.

Citizens Financial Group (CFG) — Stephens lowered its price target to $65.00 from $70.00 and maintained its Equal Weight rating.

Citizens Financial Group (CFG) — Truist Financial lowered its price target to $70.00 from $77.00 and maintained its Hold rating.

Cleveland-Cliffs (CLF) — Morgan Stanley raised its price target to $14.00 from $12.50 and maintained its Equal Weight rating.

Cleveland-Cliffs (CLF) — The Goldman Sachs Group reiterated its rating of Neutral with a $13.00 price target.

Cleveland-Cliffs (CLF) — Wells Fargo & Company raised its price target to $17.00 from $14.00 and maintained its Overweight rating.

Climb Bio (CLYM) — Deutsche Bank initiated at Buy with a $28.00 price target.

Comfort Systems USA (FIX) — The Goldman Sachs Group set a price target of $1,875.00.

Commercial Metals (CMC) — Barclays lowered its price target to $72.00 from $80.00 and maintained its Equal Weight rating.

Concentra (CON) — Stephens initiated at Overweight with a $45.00 price target.

ConocoPhillips (COP) — Susquehanna raised its price target to $175.00 from $161.00 and maintained its Positive rating.

ConocoPhillips (COP) — The Goldman Sachs Group reiterated its rating of Buy with a $157.00 price target.

CoreWeave (CRWV) — HSBC reiterated its rating of Reduce with a $39.00 price target.

Disc Medicine (IRON) — Morgan Stanley raised its price target to $92.00 from $90.00 and maintained its Overweight rating.

Disc Medicine (IRON) — Wells Fargo & Company raised its price target to $124.00 from $86.00 and maintained its Overweight rating.

Dominion Energy (D) — Mizuho lowered its price target to $67.00 from $72.00 and maintained its Neutral rating.

DraftKings (DKNG) — JPMorgan lowered its price target to $30.00 from $33.00 and maintained its Overweight rating.

DraftKings (DKNG) — Truist Financial lowered its price target to $26.00 from $29.00 and maintained its Buy rating.

Dynex Capital (DX) — Keefe, Bruyette & Woods reiterated its rating of Buy ? Hold.

Elanco Animal Health (ELAN) — Jefferies downgraded from Buy to Hold with a $24.00 price target.

Eli Lilly and Company (LLY) — The Goldman Sachs Group reiterated its rating of Buy with a $1,413.00 price target.

EMCOR Group (EME) — The Goldman Sachs Group lowered its price target to $795.00 from $885.00 and maintained its Neutral rating.

Ensysce Biosciences (ENSC) — Cantor Fitzgerald initiated at Overweight with a $2.00 price target.

Entegris (ENTG) — Citigroup reiterated its rating of Positive.

EOG Resources (EOG) — Susquehanna raised its price target to $187.00 from $170.00 and maintained its Positive rating.

Equinix (EQIX) — Guggenheim reiterated its rating of Buy with a $1,235.00 price target.

EquipmentShare.com (EQPT) — Robert W. Baird lowered its price target to $28.00 from $35.00 and maintained its Outperform rating.

Essential Properties Realty Trust (EPRT) — Barclays lowered its price target to $34.00 from $37.00 and maintained its Overweight rating.

Essential Properties Realty Trust (EPRT) — Deutsche Bank downgraded from Buy to Hold with a $28.00 price target.

Evergy (EVRG) — BTIG Research set a price target of $94.00.

Evommune (EVMN) — Morgan Stanley resumed at Overweight with a $26.00 price target.

Expedia Group (EXPE) — Melius Research set a price target of $355.00.

ExxonMobil (XOM) — The Goldman Sachs Group reiterated its rating of Equal Weight.

Eyepoint Pharmaceuticals (EYPT) — HC Wainwright reiterated its rating of Sector Perform.

EyePoint Pharmaceuticals (EYPT) — JPMorgan downgraded from Neutral to Underweight.

Eyepoint Pharmaceuticals (EYPT) — Laidlaw reiterated its rating of Buy ? Hold.

EyePoint Pharmaceuticals (EYPT) — Mizuho downgraded from Outperform to Neutral with a $0.50 price target.

Eyepoint Pharmaceuticals (EYPT) — Royal Bank Of Canada lowered its price target to $1.00 and maintained its Sector Perform rating.

Ferrovial (FER) — Deutsche Bank Aktiengesellschaft downgraded its rating from Buy to Hold.

Fifth Third Bancorp (FITB) — Royal Bank Of Canada lowered its price target to $60.00 from $62.00 and maintained its Outperform rating.

Floor & Decor (FND) — Jefferies lowered its price target to $47.00 from $59.00 and maintained its Hold rating.

Fluence Energy (FLNC) — Truist Financial lowered its price target to $8.00 from $10.00 and maintained its Hold rating.

Flutter Entertainment (FLUT) — JPMorgan lowered its price target to $110.00 from $114.00 and maintained its Neutral rating.

Flutter Entertainment (FLUT) — Truist Financial lowered its price target to $100.00 from $120.00 and maintained its Buy rating.

Fortinet (FTNT) — Truist Financial set a price target of $200.00 with a Buy rating.

Fortrea (FTRE) — UBS Group raised its price target to $24.00 from $22.00 and maintained its Neutral rating.

Four Corners Property Trust (FCPT) — Barclays lowered its price target to $25.00 from $30.00 and maintained its Equal Weight rating.

FOX (FOX) — Citigroup reiterated its Buy rating, and $78 target.

FOX (FOX) — Fox Advisors reiterated its rating.

FOX (FOX) — Royal Bank Of Canada set a price target of $95.00.

Freightos (CRGO) — Freedom Broker lowered its price target to $2.50 from $2.60 and maintained its Buy rating.

Galaxy Digital (GLXY) — Piper Sandler lowered its price target to $25.00 from $33.00 and maintained its Overweight rating.

Gaming and Leisure Properties (GLPI) — Barclays lowered its price target to $44.00 from $50.00 and maintained its Overweight rating.

Gaming and Leisure Properties (GLPI) — Truist Financial lowered its price target to $55.00 from $60.00 and maintained its Buy rating.

Gartner (IT) — Royal Bank Of Canada reiterated its rating of Sector Perform with a $198.00 price target.

Gartner (IT) — Truist Financial raised its price target to $235.00 from $205.00 and maintained its Buy rating.

Gartner (IT) — Wells Fargo & Company raised its price target to $175.00 from $150.00 and maintained its Underweight rating.

GE Aerospace (GE) — Vertical Research reiterated its rating of Buy with a $400.00 price target.

GE HealthCare (GEHC) — Wolfe Research initiated at Peer Perform.

Genmab A/S (GMAB) — Morgan Stanley set a price target of $42.00.

Gildan Activewear (GIL) — Royal Bank Of Canada lowered its price target to $70.00 from $82.00 and maintained its Outperform rating.

Gilead Sciences (GILD) — Bank of America raised its price target to $172.00 from $168.00 and maintained its Buy rating.

Glass House Brands (GLAS) — Lake Street Capital lowered its price target to $7.00 and maintained its Buy rating.

Granite Ridge Resources (GRNT) — Northland Securities set a price target of $11.00.

H2O America (HTO) — BTIG Research reiterated its rating of Buy with a $65.00 price target.

Healthcare Realty (HR) — Deutsche Bank upgraded from Hold to Buy with a $23.00 price target.

Heartflow (HTFL) — Piper Sandler reiterated its rating of Overweight with a $64.00 price target.

Heartland Express (HTLD) — Robert W. Baird downgraded from Outperform to Neutral with a $12.00 price target.

Hershey (HSY) — UBS Group reiterated its rating of Overweight.

Hubbell (HUBB) — JPMorgan resumed at Neutral with a $485.00 price target.

Hut 8 (HUT) — Piper Sandler lowered its price target to $123.00 from $143.00 and maintained its Overweight rating.

IDACORP (IDA) — BTIG Research set a price target of $153.00.

Immix Biopharma (IMMX) — Morgan Stanley set a price target of $20.00.

Incyte (INCY) — Morgan Stanley resumed at Equal-Weight with a $119.00 price target.

Insmed (INSM) — Raymond James Financial set a price target of $173.00.

Inspired Entertainment (INSE) — Truist Financial lowered its price target to $8.00 from $12.00 and maintained its Buy rating.

Inter & Co. Inc. (INTR) — UBS Group raised its price target to $10.00 from $8.80 and maintained its Buy rating.

Interactive Brokers Group (IBKR) — UBS Group set a price target of $97.00.

Ionis Pharmaceuticals (IONS) — Raymond James Financial set a price target of $79.00.

Johnson & Johnson (JNJ) — TD Cowen reiterated its rating of Underweight.

Kazia Therapeutics (KZIA) — Leerink Partners initiated at Outperform with a $30.00 price target.

Kestra Medical Technologies (KMTS) — Evercore ISI initiated at Outperform with a $34.00 price target.

Kinetik (KNTK) — Raymond James Financial reiterated its rating of Outperform with a $57.00 price target.

Kraft Heinz (KHC) — JPMorgan lowered its price target to $23.00 from $24.00 and maintained its Underweight rating.

Kulicke and Soffa Industries (KLIC) — B. Riley Financial lowered its price target to $86.00 from $105.00 and maintained its Neutral rating.

Lakefront Biotherapeutics NV (LKFT) — Morgan Stanley resumed at Equal-Weight with a $26.00 price target.

Lam Research (LRCX) — Evercore set a price target of $315.00.

Las Vegas Sands (LVS) — JPMorgan lowered its price target to $54.00 from $60.00 and maintained its Overweight rating.

Las Vegas Sands (LVS) — Stifel lowered its price target to $54.00 from $60.00 and maintained its Buy rating.

Liberty Global (LBTYA) — Barclays lowered its price target to $7.00 from $10.00 and maintained its Equal Weight rating.

Liberty Global (LBTYA) — New Street Research upgraded its rating to Buy and set a $14.00 price target.

Lineage (LINE) — UBS Group lowered its price target to $36.00 from $45.00 and maintained its Neutral rating.

Live Nation Entertainment (LYV) — CFRA downgraded from Hold to Sell.

Live Nation Entertainment (LYV) — Susquehanna lowered its price target to $183.00 from $187.00 and maintained its Neutral rating.

M&T Bank (MTB) — Truist Financial lowered its price target to $235.00 from $250.00 and maintained its Hold rating.

Mach Natural Resources (MNR) — Northland Securities set a price target of $19.00.

Manhattan Associates (MANH) — Citigroup reiterated its rating of Overweight.

MannKind (MNKD) — Cantor Fitzgerald reiterated its rating of Overweight with a $8.00 price target.

MARA (MARA) — Piper Sandler reiterated its rating of Overweight with a $11.00 price target.

Marsh & McLennan Companies (MRSH) — JPMorgan raised its price target to $218.00 from $215.00 and maintained its Overweight rating.

MaxLinear (MXL) — Wells Fargo & Company lowered its price target to $78.00 from $95.00 and maintained its Equal Weight rating.

McDonald’s (MCD) — Citigroup reiterated its rating of Equal Weight.

McKesson (MCK) — Mizuho raised its price target to $1,020.00 from $905.00 and maintained its Neutral rating.

Meta Platforms (META) — Rosenblatt Securities reiterated its rating of Buy with a $886.00 price target.

MGM Resorts International (MGM) — JPMorgan lowered its price target to $42.00 from $53.00 and maintained its Overweight rating.

MGM Resorts International (MGM) — Stifel lowered its price target to $40.00 from $49.00 and maintained its Hold rating.

MGM Resorts International (MGM) — Truist Financial lowered its price target to $45.00 from $55.00 and maintained its Buy rating.

Microchip Technology (MCHP) — Wells Fargo & Company lowered its price target to $80.00 from $88.00 and maintained its Equal Weight rating.

Microsoft (MSFT) — BMO Capital Markets raised its price target to $600.00 from $515.00 and maintained its Outperform rating.

Microsoft (MSFT) — Piper Sandler reiterated its rating of Hold.

Midera Food Processing (MFP) — William Blair initiated at Outperform.

Mobia Medical (MOBI) — BTIG Research reiterated its rating of Buy with a $19.00 price target.

Modine Manufacturing (MOD) — Cantor Fitzgerald initiated at Overweight with a $275.00 price target.

Monolithic Power Systems (MPWR) — Wells Fargo & Company lowered its price target to $1,550.00 from $1,800.00 and maintained its Overweight rating.

MPLX (MPLX) — JPMorgan resumed at Neutral with a $62.00 price target.

Myriad Genetics (MYGN) — Piper Sandler upgraded from Underweight to Neutral with a $5.00 price target.

Neostellar Capital (NSLR) — Barrington Research set a price target of $13.00.

Newmont (NEM) — Citigroup reiterated its rating of Overweight.

Newmont (NEM) — National Bank Financial lowered its price target to $135.00 from $140.00 and maintained its Sector Perform rating.

News Corp. (NWSA) — Raymond James initiated at Outperform with a $35.00 price target.

NextEra Energy (NEE) — BMO Capital Markets set a price target of $88.00.

NextEra Energy (NEE) — BTIG Research reiterated its rating of Buy with a $105.00 price target.

NextEra Energy (NEE) — Piper Sandler set a price target of $88.00.

NiSource (NI) — JPMorgan lowered its price target to $51.00 from $52.00 and maintained its Overweight rating.

NNN REIT (NNN) — Barclays lowered its price target to $43.00 from $47.00 and maintained its Underweight rating.

Northwest Natural Gas (NWN) — BTIG Research set a price target of $56.00.

Northwest Natural Gas (NWN) — Wells Fargo & Company lowered its price target to $49.00 from $50.00 and maintained its Equal Weight rating.

Norwegian Cruise Line (NCLH) — Susquehanna lowered its price target to $16.00 from $17.00 and maintained its Neutral rating.

Norwegian Cruise Line (NCLH) — TD Cowen lowered its price target to $20.00 from $24.00 and maintained its Buy rating.

NU (NU) — UBS Group raised its price target to $20.50 from $18.20 and maintained its Buy rating.

NuScale Power (SMR) — Barclays downgraded from Equal Weight to Underweight with a $5.00 price target.

nVent Electric (NVT) — JPMorgan initiated at Overweight with a $167.00 price target.

NXP Semiconductors (NXPI) — Wells Fargo & Company lowered its price target to $235.00 from $280.00 and maintained its Equal Weight rating.

O’Reilly Automotive (ORLY) — Royal Bank Of Canada reiterated its rating of Outperform with a $111.00 price target.

Occidental Petroleum (OXY) — Susquehanna raised its price target to $77.00 from $70.00 and maintained its Positive rating.

Ocular Therapeutix (OCUL) — HC Wainwright reiterated its rating of Equal Weight.

OGE Energy (OGE) — Wells Fargo & Company raised its price target to $49.00 from $48.00 and maintained its Equal Weight rating.

Oklo (OKLO) — Barclays lowered its price target to $59.00 from $76.00 and maintained its Overweight rating.

Olin (OLN) — Truist Financial lowered its price target to $15.00 from $20.00 and maintained its Hold rating.

ON (ONON) — Jefferies reiterated its rating.

ONE Gas (OGS) — BTIG Research set a price target of $89.00.

ONEOK (OKE) — Raymond James Financial reiterated its rating of Outperform with a $98.00 price target.

Onto Innovation (ONTO) — Cantor Fitzgerald reiterated its rating of Outperform.

Ovintiv (OVV) — National Bank Financial raised its price target to $94.00 from $91.00 and maintained its Outperform rating.

Palvella Therapeutics (PVLA) — HC Wainwright reiterated its rating of Outperform.

Paylocity (PCTY) — Citigroup reiterated its rating of Hold ? Buy.

Paylocity (PCTY) — Citizens Jmp raised its price target to $180.00 from $150.00 and maintained its Market Outperform rating.

PENN Entertainment (PENN) — JPMorgan lowered its price target to $24.00 from $27.00 and maintained its Overweight rating.

Permian Resources (PR) — Susquehanna raised its price target to $30.00 from $25.00 and maintained its Positive rating.

Phreesia (PHR) — Citigroup reiterated its rating of Neutral.

Pool (POOL) — Stifel lowered its price target to $175.00 from $189.00 and maintained its Hold rating.

Portland General Electric (POR) — BTIG Research set a price target of $57.00.

PPL (PPL) — BTIG Research reiterated its rating of Buy with a $41.00 price target.

Precision Drilling (PDS) — TD Securities upgraded its rating from Hold to Buy.

Principal Financial Group (PFG) — Wells Fargo & Company lowered its price target to $112.00 from $113.00 and maintained its Equal Weight rating.

Private Bancorp (PBAM) — DA Davidson raised its price target to $107.00 from $105.00 and maintained its Buy rating.

Private Bancorp (PBAM) — Piper Sandler raised its price target to $101.00 from $96.00 and maintained its Overweight rating.

Procter & Gamble (PG) — Royal Bank Of Canada reiterated its rating of Outperform with a $166.00 price target.

Prologis (PLD) — Robert W. Baird lowered its price target to $136.00 from $140.00 and maintained its Neutral rating.

PTC Therapeutics (PTCT) — Raymond James Financial set a price target of $106.00.

Public Storage (PSA) — Royal Bank Of Canada reiterated its rating of Sector Perform with a $318.00 price target.

Range Resources (RRC) — Susquehanna raised its price target to $44.00 from $41.00 and maintained its Neutral rating.

Rapport Therapeutics (RAPP) — BTIG Research raised its price target to $89.00 from $75.00 and maintained its Buy rating.

Rapport Therapeutics (RAPP) — HC Wainwright reiterated its rating of Buy with a $66.00 price target.

Rapport Therapeutics (RAPP) — Raymond James Financial reiterated its rating of Strong-Buy with a $86.00 price target.

Rapport Therapeutics (RAPP) — TD Cowen reiterated its rating of Strong-Buy.

Realty Income (O) — Barclays lowered its price target to $61.00 from $65.00 and maintained its Equal Weight rating.

Red Cat (RCAT) — Needham & Company LLC reiterated its rating of Buy with a $15.00 price target.

Red Rock Resorts (RRR) — JPMorgan lowered its price target to $71.00 from $72.00 and maintained its Overweight rating.

Regions Financial (RF) — Truist Financial lowered its price target to $30.00 from $31.00 and maintained its Hold rating.

RELX (RELX) — Citigroup downgraded from Buy to Neutral.

Restaurant Brands International (QSR) — Citigroup reiterated its rating of Buy.

Restaurant Brands International (QSR) — Mizuho initiated at Outperform with a $85.00 price target.

RH (RH) — The Goldman Sachs Group lowered its price target to $140.00 from $164.00 and maintained its Neutral rating.

Robinhood Markets (HOOD) — JPMorgan raised its price target to $115.00 from $103.00 and maintained its Neutral rating.

Rogers Communication (RCI) — Scotiabank reiterated its rating of Buy.

Royal Caribbean Cruises (RCL) — Susquehanna lowered its price target to $355.00 from $372.00 and maintained its Positive rating.

Royal Caribbean Cruises (RCL) — TD Cowen raised its price target to $340.00 from $337.00 and maintained its Buy rating.

Royal Gold (RGLD) — TD lowered its price target to $311.00 from $315.00 and maintained its Buy rating.

Rush Street Interactive (RSI) — JPMorgan lowered its price target to $22.00 from $30.00 and maintained its Neutral rating.

Salesforce (CRM) — Citigroup reiterated its Hold rating, $263 target.

Salesforce (CRM) — Evercore reiterated its Outperform rating, $290 target.

Salesforce (CRM) — Jefferies reiterated its rating of Buy.

SBA Communications (SBAC) — Sanford C. Bernstein lowered its price target to $208.00 from $219.00 and maintained its Market Perform rating.

Schrodinger (SDGR) — UBS Group raised its price target to $21.00 from $19.00 and maintained its Neutral rating.

Seagate Technology (STX) — Morgan Stanley raised its price target to $1,200.00 from $1,187.00 and maintained its Overweight rating.

Sempra Energy (SRE) — BTIG Research set a price target of $100.00.

ServiceNow (NOW) — Sanford C. Bernstein reiterated its rating of Outperform with a $266.00 price target.

SiTime (SITM) — Rosenblatt initiated at Buy with a $750.00 price target.

SM Energy (SM) — Susquehanna raised its price target to $44.00 from $32.00 and maintained its Neutral rating.

Southern (SO) — Jefferies set a price target of $95.00.

Southwest Gas (SWX) — JPMorgan lowered its price target to $101.00 from $102.00 and maintained its Overweight rating.

SpaceX (SPCX) — Cantor Fitzgerald reiterated its rating of Neutral.

Spire (SR) — JPMorgan raised its price target to $86.00 from $85.00 and maintained its Neutral rating.

Sportradar Group (SRAD) — JPMorgan lowered its price target to $13.00 from $15.00 and maintained its Neutral rating.

Spotify Technology (SPOT) — Rosenblatt Securities reiterated its rating of Neutral with a $527.00 price target.

Sprouts Farmers Market (SFM) — Royal Bank Of Canada lowered its price target to $111.00 from $114.00 and maintained its Outperform rating.

SPS Commerce (SPSC) — Citigroup reiterated its rating of Neutral.

Starbucks (SBUX) — Citigroup reiterated its rating of Neutral.

Steel Dynamics (STLD) — The Goldman Sachs Group reiterated its rating of Buy with a $299.00 price target.

Sunoco (SUN) — JPMorgan resumed at Overweight with a $87.00 price target.

Synchrony Financial (SYF) — Jefferies reiterated its rating of Buy with a $103.00 price target.

Synchrony Financial (SYF) — Royal Bank Of Canada reiterated its rating of Outperform.

Synopsys (SNPS) — Morgan Stanley raised its price target to $574.00 from $500.00 and maintained its Overweight rating.

Tapestry (TPR) — UBS Group lowered its price target to $200.00 from $232.00 and maintained its Buy rating.

Targa Resources (TRGP) — Raymond James Financial reiterated its rating of Strong-Buy with a $340.00 price target.

Teck Resources (TECK) — Stifel raised its price target to $95.00 from $82.00 and maintained its Hold rating.

Tenable (TENB) — Truist Financial raised its price target to $35.00 from $30.00 and maintained its Hold rating.

Texas Instruments (TXN) — Cantor Fitzgerald reiterated its Hold rating, and $340 target.

Texas Instruments (TXN) — Wells Fargo & Company lowered its price target to $300.00 from $310.00 and maintained its Equal Weight rating.

Thomson Reuters (TRI) — Jefferies initiated at Buy with a $130.00 price target.

TKO Group (TKO) — Guggenheim lowered its price target to $228.00 from $235.00 and maintained its Buy rating.

TKO Group Holdings (TKO) — Arete upgraded from Neutral to Buy with a $208.00 price target.

Tonix Pharmaceuticals (TNXP) — Raymond James Financial reiterated its rating of Buy.

Torrid (CURV) — William Blair reiterated its rating of Buy.

Travelers Companies (TRV) — BMO Capital Markets set a price target of $388.00.

Travelers Companies (TRV) — JPMorgan raised its price target to $379.00 from $352.00 and maintained its Neutral rating.

Travelers Companies (TRV) — Keefe, Bruyette & Woods raised its price target to $382.00 from $372.00 and maintained its Market Perform rating.

Travelers Companies (TRV) — Mizuho raised its price target to $371.00 from $345.00 and maintained its Neutral rating.

Trex (TREX) — Stifel upgraded from Hold to Buy with a $55.00 price target.

Trinity Industries (TRN) — The Goldman Sachs Group set a price target of $30.00.

Tronox (TROX) — Truist Financial lowered its price target to $4.00 from $7.00 and maintained its Hold rating.

Truist Financial (TFC) — Stephens lowered its price target to $54.00 from $55.00 and maintained its Overweight rating.

Tvardi Therapeutics (TVRD) — Chardan Capital Markets initiated at Buy with a $8.00 price target.

UMB Financial (UMBF) — Truist Financial lowered its price target to $156.00 from $170.00 and maintained its Buy rating.

United Airlines (UAL) — Sanford C. Bernstein set a price target of $160.00.

United Therapeutics (UTHR) — Raymond James Financial reiterated its rating of Outperform with a $717.00 price target.

UnitedHealth Group (UNH) — Royal Bank Of Canada raised its price target to $498.00 from $478.00 and maintained its Outperform rating.

Venture Global (VG) — Wells Fargo upgraded from Equal Weight to Overweight with a $21.00 price target.

Vertiv (VRT) — Roth Capital reiterated its rating of Overweight.

VICI Properties (VICI) — Barclays lowered its price target to $28.00 from $31.00 and maintained its Overweight rating.

VICI Properties (VICI) — Truist Financial lowered its price target to $32.00 from $38.00 and maintained its Buy rating.

Vicor (VICR) — Needham & Company LLC reiterated its rating of Buy with a $350.00 price target.

Victoria’s Secret & Co. (VSXY) — Barclays raised its price target to $112.00 from $106.00 and maintained its Overweight rating.

Viking (VIK) — Susquehanna lowered its price target to $100.00 from $105.00 and maintained its Positive rating.

Viking Therapeutics (VKTX) — Canaccord Genuity Group lowered its price target to $106.00 from $114.00 and maintained its Buy rating.

VinFast Auto (VFS) — Cantor Fitzgerald lowered its price target to $4.00 from $5.00 and maintained its Overweight rating.

Vodafone (VOD) — Barclays downgraded from Equal Weight to Underweight.

W.P. Carey (WPC) — Barclays lowered its price target to $76.00 from $80.00 and maintained its Equal Weight rating.

W.R. Berkley (WRB) — Mizuho raised its price target to $73.00 from $70.00 and maintained its Neutral rating.

W.R. Berkley (WRB) — Wells Fargo & Company reiterated its rating of Underweight with a $68.00 price target.

Wabash National (WNC) — National Bank Financial set a price target of $25.00.

Walmart (WMT) — Evercore reiterated its Buy rating, raised target to $130.00 from $125.00.

Wayfair (W) — Piper Sandler raised its price target to $135.00 from $133.00 and maintained its Overweight rating.

WEC Energy Group (WEC) — BTIG Research set a price target of $127.00.

Werner Enterprises (WERN) — Robert W. Baird downgraded from Outperform to Neutral with a $32.00 price target.

Werner Enterprises (WERN) — Bank of America lowered its price target to $32.00 from $40.00 and maintained its Underperform rating.

Werner Enterprises (WERN) — Barclays lowered its price target to $38.00 from $40.00 and maintained its Equal Weight rating.

Werner Enterprises (WERN) — Wells Fargo & Company lowered its price target to $35.00 from $37.00 and maintained its Equal Weight rating.

Western Alliance Bancorporation (WAL) — DA Davidson set a price target of $107.00.

Western Alliance Bancorporation (WAL) — Piper Sandler set a price target of $96.00.

Western Digital (WDC) — Morgan Stanley lowered its price target to $643.00 from $676.00 and maintained its Overweight rating.

Western Midstream (WES) — JPMorgan resumed at Neutral with a $50.00 price target.

Williams-Sonoma (WSM) — Evercore set a price target of $255.00.

Williams-Sonoma (WSM) — Piper Sandler reiterated its rating of Overweight with a $286.00 price target.

Wintrust Financial (WTFC) — DA Davidson set a price target of $180.00.

Wynn Resorts (WYNN) — JPMorgan lowered its price target to $115.00 from $134.00 and maintained its Overweight rating.

Wynn Resorts (WYNN) — Stifel lowered its price target to $120.00 from $143.00 and maintained its Buy rating.

Wynn Resorts (WYNN) — Truist Financial lowered its price target to $110.00 from $125.00 and maintained its Buy rating.

Wynn Resorts (WYNN) — UBS Group set a price target of $120.00.

Xcel Energy (XEL) — BMO Capital Markets set a price target of $86.00.

Xcel Energy (XEL) — BTIG Research reiterated its rating of Buy with a $91.00 price target.

Xcel Energy (XEL) — Jefferies reiterated its rating of Buy with a $99.00 price target.

Xcel Energy (XEL) — Royal Bank Of Canada set a price target of $86.00.

Zenas Biopharma (ZBIO) — Morgan Stanley resumed at Equal-Weight with a $32.00 price target.

Zions Bancorporation, N.A. (ZION) — DA Davidson raised its price target to $80.00 from $79.00 and maintained its Buy rating.

Zions Bancorporation, N.A. (ZION) — JPMorgan raised its price target to $87.00 from $86.00 and maintained its Underweight rating.

Zions Bancorporation, N.A. (ZION) — Morgan Stanley lowered its price target to $77.00 from $78.00 and maintained its Underweight rating.

Zions Bancorporation, N.A. (ZION) — Royal Bank Of Canada reiterated its rating of Sector Perform with a $76.00 price target.

Zions Bancorporation, N.A. (ZION) — TD Cowen reiterated its rating of Hold with a $69.00 price target.

Zoetis (ZTS) — Jefferies downgraded from Buy to Hold with a $83.00 price target.

Join the discussion

Your email address will not be published. Required fields are marked *